217 related articles for article (PubMed ID: 29124671)
1. Mutations of N-Methyl-D-Aspartate Receptor Subunits in Epilepsy.
Xu XX; Luo JH
Neurosci Bull; 2018 Jun; 34(3):549-565. PubMed ID: 29124671
[TBL] [Abstract][Full Text] [Related]
2. Two patients with a GRIN2A mutation and childhood-onset epilepsy.
DeVries SP; Patel AD
Pediatr Neurol; 2013 Dec; 49(6):482-5. PubMed ID: 24125812
[TBL] [Abstract][Full Text] [Related]
3. Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy.
Xu XX; Liu XR; Fan CY; Lai JX; Shi YW; Yang W; Su T; Xu JY; Luo JH; Liao WP
Neurosci Bull; 2018 Apr; 34(2):237-246. PubMed ID: 28936771
[TBL] [Abstract][Full Text] [Related]
4. NMDA receptor subunit mutations in neurodevelopmental disorders.
Burnashev N; Szepetowski P
Curr Opin Pharmacol; 2015 Feb; 20():73-82. PubMed ID: 25498981
[TBL] [Abstract][Full Text] [Related]
5. Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations.
Serraz B; Grand T; Paoletti P
Neuropharmacology; 2016 Oct; 109():196-204. PubMed ID: 27288002
[TBL] [Abstract][Full Text] [Related]
6. GRIN2A mutations in epilepsy-aphasia spectrum disorders.
Yang X; Qian P; Xu X; Liu X; Wu X; Zhang Y; Yang Z
Brain Dev; 2018 Mar; 40(3):205-210. PubMed ID: 29056244
[TBL] [Abstract][Full Text] [Related]
7. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of NMDA Receptor Variants in Neurodevelopmental Disorders and Epilepsy.
Gjerulfsen CE; Krey I; Klöckner C; Rubboli G; Lemke JR; Møller RS
Methods Mol Biol; 2024; 2799():1-11. PubMed ID: 38727899
[TBL] [Abstract][Full Text] [Related]
9. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
[TBL] [Abstract][Full Text] [Related]
10. Functional Evaluation of a De Novo
Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
[TBL] [Abstract][Full Text] [Related]
11. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.
Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N
Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721
[TBL] [Abstract][Full Text] [Related]
12. Gene Targeted Mice with Conditional Knock-In (-Out) of NMDAR Mutations.
Sprengel R; Eltokhi A; Single FN
Methods Mol Biol; 2017; 1677():201-230. PubMed ID: 28986875
[TBL] [Abstract][Full Text] [Related]
13. Amygdala gene expression of NMDA and GABA(A) receptors in patients with mesial temporal lobe epilepsy.
de Moura JC; Tirapelli DP; Neder L; Saggioro FP; Sakamoto AC; Velasco TR; Panepucci RA; Leite JP; Assirati Júnior JA; Colli BO; Carlotti Júnior CG
Hippocampus; 2012 Jan; 22(1):92-7. PubMed ID: 20848605
[TBL] [Abstract][Full Text] [Related]
14. The NMDA receptor complex as a therapeutic target in epilepsy: a review.
Ghasemi M; Schachter SC
Epilepsy Behav; 2011 Dec; 22(4):617-40. PubMed ID: 22056342
[TBL] [Abstract][Full Text] [Related]
15. Clinical and therapeutic significance of genetic variation in the GRIN gene family encoding NMDARs.
Benke TA; Park K; Krey I; Camp CR; Song R; Ramsey AJ; Yuan H; Traynelis SF; Lemke J
Neuropharmacology; 2021 Nov; 199():108805. PubMed ID: 34560056
[TBL] [Abstract][Full Text] [Related]
16. Functional Properties of Human NMDA Receptors Associated with Epilepsy-Related Mutations of GluN2A Subunit.
Sibarov DA; Bruneau N; Antonov SM; Szepetowski P; Burnashev N; Giniatullin R
Front Cell Neurosci; 2017; 11():155. PubMed ID: 28611597
[TBL] [Abstract][Full Text] [Related]
17. The role of NMDA receptor and neuroligin rare variants in synaptic dysfunction underlying neurodevelopmental disorders.
Vieira MM; Jeong J; Roche KW
Curr Opin Neurobiol; 2021 Aug; 69():93-104. PubMed ID: 33823469
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of entorhinal cortex and hippocampal subfields α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors enhanced learning and memory of rats following administration of Centella asiatica.
Wong JH; Muthuraju S; Reza F; Senik MH; Zhang J; Mohd Yusuf Yeo NAB; Chuang HG; Jaafar H; Yusof SR; Mohamad H; Tengku Muhammad TS; Ismail NH; Husin SS; Abdullah JM
Biomed Pharmacother; 2019 Feb; 110():168-180. PubMed ID: 30469081
[TBL] [Abstract][Full Text] [Related]
19. GRIN2A-related epilepsy and speech disorders: A comprehensive overview with a focus on the role of precision therapeutics.
Samanta D
Epilepsy Res; 2023 Jan; 189():107065. PubMed ID: 36516565
[TBL] [Abstract][Full Text] [Related]
20. Adapting the endoplasmic reticulum proteostasis rescues epilepsy-associated NMDA receptor variants.
Zhang PP; Benske TM; Ahn LY; Schaffer AE; Paton JC; Paton AW; Mu TW; Wang YJ
Acta Pharmacol Sin; 2024 Feb; 45(2):282-297. PubMed ID: 37803141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
